Accelerating genomic profiling with automated sequencing

Genomic profiling is a key tool in the treatment of cancer and the study of oncology and other disease areas. By accelerating the process and automating steps, genomic profiles can be generated and accessed more rapidly in the clinic, and reproducibility can be improved in research. But how can this be done? And what are the potential impacts? Andy Felton is the vice president of product management for clinical next-generation sequencing and oncology at Thermo Fisher Scientific (MA, USA). Thermo Fisher Scientific is one of the world’s largest scientific tool providing companies. Andy’s division is specifically involved with producing and...

To view the full article, please register now for access

It's completely free